See my comments about their treatments above.
In addition and IMO Phase 1 trials are very high risk for patients, unless there is prior in-human data available or it really is last resort.
The trial I went into last year was Phase 2 and I only enrolled knowing Phase 2 results of the same trial treatment combined with a different checkpoint inhibitor. Response rate was quite good and better than Standard of Care, however not every patient achieves complete and durable response ( the case for me ).
General comments/chat, page-37887
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.00M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $19.18K | 2.882M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 18311843 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 8042563 | 29 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| ADN (ASX) Chart |